|
1
|
Labovsky V, Martinez LM, Davies KM,
García-Rivello H, Calcagno Mde L, Matas A, Fernández Vallone VB,
Wernicke A, Choi H and Chasseing NA: Association between ligands
and receptors related to the progression of early breast cancer in
tumor epithelial and stromal cells. Clin Breast Cancer. 15:e13–e21.
2015. View Article : Google Scholar
|
|
2
|
Sung B, Park B, Yadav VR and Aggarwal BB:
Celastrol, a triterpene, enhances TRAIL-induced apoptosis through
the down-regulation of cell survival proteins and up-regulation of
death receptors. J Biol Chem. 285:11498–11507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mandal C, Dutta A, Mallick A, Chandra S,
Misra L, Sangwan RS and Mandal C: Withaferin A induces apoptosis by
activating p38 mitogen-activated protein kinase signaling cascade
in leukemic cells of lymphoid and myeloid origin through
mitochondrial death cascade. Apoptosis. 13:1450–1464. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang DW, Lee JY, Oh DH, Park SY, Woo TM,
Kim MK, Park MH, Jang YH and Min do S: Triptolide-induced
suppression of phospholipase D expression inhibits proliferation of
MDA-MB-231 breast cancer cells. Exp Mol Med. 41:678–685. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen BJ: Triptolide, a novel
immunosuppressive and anti-inflammatory agent purified from a
Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma.
42:253–265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu WY and Wang YP: Pharmacological actions
and therapeutic applications of Salvia miltiorrhiza depside salt
and its active components. Acta Pharmacol Sin. 33:1119–1130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kiviharju TM, Lecane PS, Sellers RG and
Peehl DM: Antiproliferative and proapoptotic activities of
triptolide (PG490), a natural product entering clinical trials, on
primary cultures of human prostatic epithelial cells. Clin Cancer
Res. 8:2666–2674. 2002.PubMed/NCBI
|
|
8
|
Fidler JM, Li K, Chung C, Wei K, Ross JA,
Gao M and Rosen GD: PG490-88, a derivative of triptolide, causes
tumor regression and sensitizes tumors to chemotherapy. Mol Cancer
Ther. 2:855–862. 2003.PubMed/NCBI
|
|
9
|
Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei
XF, Yang J, Underhill CB and Zhang L: Triptolide inhibits the
growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72.
2003.PubMed/NCBI
|
|
10
|
Tengchaisri T, Chawengkirttikul R,
Rachaphaew N, Reutrakul V, Sangsuwan R and Sirisinha S: Antitumor
activity of triptolide against cholangiocarcinoma growth in vitro
and in hamsters. Cancer Lett. 133:169–175. 1998. View Article : Google Scholar
|
|
11
|
Liu H, Liu ZH, Chen ZH, Yang JW and Li LS:
Triptolide: A potent inhibitor of NF-kappa B in T-lymphocytes. Acta
Pharmacol Sin. 21:782–786. 2000.
|
|
12
|
Lu L, Kanwar J, Schmitt S, Cui QC, Zhang
C, Zhao C and Dou QP: Inhibition of tumor cellular proteasome
activity by triptolide extracted from the Chinese medicinal plant
'thunder god vineʼ. Anticancer Res. 31:1–10. 2011.PubMed/NCBI
|
|
13
|
Yang H, Shi G and Dou QP: The tumor
proteasome is a primary target for the natural anticancer compound
Withaferin A isolated from 'Indian winter cherryʼ. Mol Pharmacol.
71:426–437. 2007. View Article : Google Scholar
|
|
14
|
Perrone G, Hideshima T, Ikeda H, Okawa Y,
Calabrese E, Gorgun G, Santo L, Cirstea D, Raje N, Chauhan D, et
al: Ascorbic acid inhibits antitumor activity of bortezomib in
vivo. Leukemia. 23:1679–1686. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao G, Vaszar LT, Qiu D, Shi L and Kao
PN: Anti-inflammatory effects of triptolide in human bronchial
epithelial cells. Am J Physiol Lung Cell Mol Physiol.
279:L958–L966. 2000.PubMed/NCBI
|
|
16
|
Sethi G, Ahn KS and Aggarwal BB: Targeting
nuclear factor-kappa B activation pathway by thymoquinone: Role in
suppression of antiapoptotic gene products and enhancement of
apoptosis. Mol Cancer Res. 6:1059–1070. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Eckelman BP, Salvesen GS and Scott FL:
Human inhibitor of apoptosis proteins: Why XIAP is the black sheep
of the family. Embo Rep. 7:988–994. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Srinivasula SM, Hegde R, Saleh A, Datta P,
Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y
and Alnemri E: A conserved XIAP-interaction motif in caspase-9 and
Smac/DIABLO regulates caspase activity and apoptosis. Nature.
410:112–116. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baeuerle PA and Baltimore D: NF-kappa B:
Ten years after. Cell. 87:13–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao Y, Fu Y, Hu J, Liu Y and Yin X: The
effect of tissue factor pathway inhibitor on the expression of
monocyte chemotactic protein-3 and IκB-α stimulated by tumour
necrosis factor-α in cultured vascular smooth muscle cells. Arch
Cardiovasc Dis. 106:4–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gyrd-Hansen M and Meier P: IAPs: From
caspase inhibitors to modulators of NF-kappaB, inflammation and
cancer. Nat Rev Cancer. 10:561–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takada Y, Singh S and Aggarwal BB:
Identification of a p65 peptide that selectively inhibits NF-kappa
B activation induced by various inflammatory stimuli and its role
in down-regulation of NF-kappaB-mediated gene expression and
up-regulation of apoptosis. J Biol Chem. 279:15096–15104. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vile GF, Tanew-Ilitschew A and Tyrrell RM:
Activation of NF-kappa B in human skin fibroblasts by the oxidative
stress generated by UVA radiation. Photochem Photobiol. 62:463–468.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Varfolomeev E, Goncharov T, Fedorova AV,
Dynek JN, Zobel K, Deshayes K, Fairbrother WJ and Vucic D: c-IAP1
and c-IAP2 are critical mediators of tumor necrosis factor alpha
(TNFalpha)-induced NF-kappaB activation. J Biol Chem.
283:24295–24299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salvesen GS and Duckett CS: IAP proteins:
Blocking the road to death's door. Nat Rev Mol Cell Biol.
3:401–410. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rothe M, Pan MG, Henzel WJ, Ayres TM and
Goeddel DV: The TNFR2-TRAF signaling complex contains two novel
proteins related to baculoviral inhibitor of apoptosis proteins.
Cell. 83:1243–1252. 1995. View Article : Google Scholar : PubMed/NCBI
|
